Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculo...
Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)
About this item
Full title
Author / Creator
Borand, Laurence , Madec, Yoann , Laureillard, Didier , Chou, Monidarin , Marcy, Olivier , Pheng, Phearavin , Prak, Narom , Kim, Chindamony , Lak, Khemarin Kim , Hak, Chanroeun , Dim, Bunnet , Nerrienet, Eric , Fontanet, Arnaud , Sok, Thim , Goldfeld, Anne E. , Blanc, François-Xavier and Taburet, Anne-Marie
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.
HIV-infected adults with CD4+ T cell count ≤ 200/mm(3) received standard 6-month tuberculosis treatment and antiretroviral therapy including a daily-dose of 600 mg of efavirenz,...
Alternative Titles
Full title
Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1504977557
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1504977557
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0090350
